Common Stock, Shares Authorized of Zeo ScientifiX, Inc. from Q2 2011 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Zeo ScientifiX, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q2 2011 to Q2 2025.
  • Zeo ScientifiX, Inc. Common Stock, Shares Authorized for the quarter ending 31 Jul 2025 was 2.5B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Zeo ScientifiX, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 2.5B 0 0% 31 Jul 2025 10-Q 15 Sep 2025
Q1 2025 2.5B 0 0% 30 Apr 2025 10-Q 16 Jun 2025
Q4 2024 2.5B 0 0% 31 Jan 2025 10-Q 17 Mar 2025
Q3 2024 2.5B 0 0% 31 Oct 2024 10-Q 15 Sep 2025
Q2 2024 2.5B 0 0% 31 Jul 2024 10-Q 16 Sep 2024
Q1 2024 2.5B 0 0% 30 Apr 2024 10-Q 14 Jun 2024
Q4 2023 2.5B 0 0% 31 Jan 2024 10-Q 18 Mar 2024
Q3 2023 2.5B 0 0% 31 Oct 2023 10-K 29 Jan 2025
Q2 2023 2.5B 0 0% 15 Jun 2023 10-Q 16 Jun 2023
Q1 2023 2.5B 0 0% 30 Apr 2023 10-Q 16 Jun 2023
Q4 2022 2.5B 0 0% 31 Jan 2023 10-Q 17 Mar 2023
Q3 2022 2.5B 0 0% 31 Oct 2022 10-K 29 Jan 2024
Q2 2022 2.5B 0 0% 31 Jul 2022 10-Q 14 Sep 2022
Q1 2022 2.5B 0 0% 16 Mar 2022 10-Q 17 Mar 2023
Q4 2021 2.5B 0 0% 31 Jan 2022 10-Q 16 Mar 2022
Q3 2021 2.5B 0 0% 31 Oct 2021 10-K 14 Feb 2023
Q2 2021 2.5B +1B +66.7% 01 Jun 2021 10-Q 14 Jun 2021
Q1 2021 2.5B +1B +66.7% 30 Apr 2021 10-Q 14 Jun 2021
Q4 2020 2.5B +1B +66.7% 04 Jan 2021 10-K 14 Feb 2023
Q3 2020 2.5B +1B +66.7% 31 Oct 2020 10-K 14 Feb 2022
Q2 2020 1.5B 0 0% 31 Jul 2020 10-Q 18 Dec 2020
Q1 2020 1.5B 0 0% 30 Apr 2020 10-Q 17 Dec 2020
Q4 2019 1.5B 0 0% 31 Jan 2020 10-Q 17 Dec 2020
Q3 2019 1.5B 0 0% 31 Oct 2019 10-K 08 Feb 2021
Q2 2019 1.5B +750M +100% 31 Jul 2019 10-Q 16 Oct 2020
Q1 2019 1.5B +750M +100% 30 Apr 2019 10-Q 16 Oct 2020
Q4 2018 1.5B +750M +100% 31 Jan 2019 10-Q 16 Oct 2020
Q3 2018 1.5B +750M +100% 31 Oct 2018 10-K 16 Oct 2020
Q2 2018 750M 0 0% 31 Jul 2018 10-Q 06 Mar 2020
Q1 2018 750M 0 0% 30 Apr 2018 10-Q 06 Mar 2020
Q4 2017 750M 0 0% 31 Jan 2018 10-Q 06 Mar 2020
Q3 2017 750M 0 0% 31 Oct 2017 10-K 06 Mar 2020
Q2 2017 750M +500M +200% 31 Jul 2017 10-Q 19 Sep 2017
Q1 2017 750M +500M +200% 30 Apr 2017 10-Q 14 Jul 2017
Q4 2016 750M +500M +200% 31 Jan 2017 10-Q 12 Jul 2017
Q3 2016 750M 0 0% 31 Oct 2016 10-K 01 Nov 2018
Q2 2016 250M 0 0% 31 Jul 2016 10-Q 26 Oct 2016
Q1 2016 250M +160M +178% 30 Apr 2016 10-Q 22 Aug 2016
Q4 2015 250M +160M +178% 31 Jan 2016 10-Q 08 Aug 2016
Q3 2015 750M +500M +200% 31 Oct 2015 10-K 07 Jul 2017
Q2 2015 250M +160M +178% 31 Jul 2015 10-Q 29 Oct 2015
Q1 2015 90M 0 0% 30 Apr 2015 10-Q 15 Jun 2015
Q4 2014 90M 0 0% 31 Jan 2015 10-Q 11 Mar 2015
Q3 2014 250M +160M +178% 31 Oct 2014 10-K 22 Jun 2016
Q2 2014 90M 0 0% 31 Jul 2014 10-Q 15 Sep 2014
Q1 2014 90M 0 0% 30 Apr 2014 10-Q 23 Jun 2014
Q4 2013 90M 0 0% 31 Jan 2014 10-Q 17 Mar 2014
Q3 2013 90M 0 0% 31 Oct 2013 10-K 17 Feb 2015
Q2 2013 90M 31 Jul 2013 10-Q 11 Aug 2014
Q1 2013 90M 30 Apr 2013 10-Q 14 Jun 2013
Q4 2012 90M 31 Jan 2013 10-Q 18 Mar 2013
Q3 2012 90M 0 0% 31 Oct 2012 10-Q 11 Aug 2014
Q3 2011 90M 31 Oct 2011 10-K 13 Feb 2013
Q2 2011 90M 09 Aug 2011 10-Q 15 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.